Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Neisseria meningitidis serogroup B"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 171
Tytuł:
Pediatric Invasive Meningococcal Disease, Auckland, New Zealand (Aotearoa), 2004-2020.
Autorzy:
Burton C
Best E
Broom M
Heffernan H
Briggs S
Webb R
Pokaż więcej
Źródło:
Emerging infectious diseases [Emerg Infect Dis] 2023 Apr; Vol. 29 (4), pp. 686-695.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Meningococcal Infections*/epidemiology
Meningococcal Infections*/prevention & control
Neisseria meningitidis*
Neisseria meningitidis, Serogroup B*
Meningococcal Vaccines*
Child ; Humans ; New Zealand/epidemiology ; Serogroup
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Whole genome analysis of Neisseria meningitidis isolates from invasive meningococcal disease collected in the Czech Republic over 28 years (1993-2020).
Autorzy:
Honskus M; National Reference Laboratory for Meningococcal Infections, Centre for Epidemiology and Microbiology, National Institute of Public Health, Prague, Czech Republic.; Third Faculty of Medicine, Charles University, Prague, Czech Republic.
Krizova P; National Reference Laboratory for Meningococcal Infections, Centre for Epidemiology and Microbiology, National Institute of Public Health, Prague, Czech Republic.
Okonji Z; National Reference Laboratory for Meningococcal Infections, Centre for Epidemiology and Microbiology, National Institute of Public Health, Prague, Czech Republic.
Musilek M; National Reference Laboratory for Meningococcal Infections, Centre for Epidemiology and Microbiology, National Institute of Public Health, Prague, Czech Republic.
Kozakova J; National Reference Laboratory for Meningococcal Infections, Centre for Epidemiology and Microbiology, National Institute of Public Health, Prague, Czech Republic.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Mar 13; Vol. 18 (3), pp. e0282971. Date of Electronic Publication: 2023 Mar 13 (Print Publication: 2023).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Neisseria meningitidis*
Meningococcal Infections*/epidemiology
Meningococcal Vaccines*
Neisseria meningitidis, Serogroup B*/genetics
Humans ; Czech Republic/epidemiology ; Vaccination ; Whole Genome Sequencing ; Serogroup ; Vaccines, Synthetic/genetics ; Antigens, Bacterial
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
FHbp variants among meningococci of serogroup B in Italy: Evolution and selective pressure, 2014-2017.
Autorzy:
Lo Presti A; Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
Carannante A; Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
Fazio C; Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
Neri A; Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
Vacca P; Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
Ambrosio L; Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
Lista F; Scientific Department, Army Medical Center, Rome, Italy.
Fillo S; Scientific Department, Army Medical Center, Rome, Italy.
Stefanelli P; Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Feb 16; Vol. 18 (2), pp. e0277976. Date of Electronic Publication: 2023 Feb 16 (Print Publication: 2023).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Neisseria meningitidis*/genetics
Neisseria meningitidis, Serogroup B*/genetics
Meningococcal Infections*/epidemiology
Meningococcal Infections*/genetics
Meningococcal Vaccines*
Humans ; Bacterial Proteins/genetics ; Antigens, Bacterial/genetics ; Carrier Proteins/genetics ; Complement Factor H/genetics ; Serogroup ; Phylogeny ; Italy
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Validity of university students' self-reported vaccination status after a meningococcal B outbreak.
Autorzy:
Ulrich AK; School of Public Health, Division of Epidemiology and Community Health, University of Minnesota, Minneapolis, Minnesota, USA.
McKearnan SB; School of Public Health, Division of Biostatistics, University of Minnesota, Minneapolis, Minnesota, USA.
Lammert S; School of Public Health, Division of Epidemiology and Community Health, University of Minnesota, Minneapolis, Minnesota, USA.
Wolfson J; School of Public Health, Division of Biostatistics, University of Minnesota, Minneapolis, Minnesota, USA.
Pletcher J; Princeton University, University Health Services, Princeton, New Jersey, USA.
Halloran ME; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; School of Public Health, Department of Biostatistics, University of Washington, Seattle, Washington, USA.
Basta NE; Faculty of Medicine, Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Quebec, Canada.
Pokaż więcej
Źródło:
Journal of American college health : J of ACH [J Am Coll Health] 2022 Apr; Vol. 70 (3), pp. 824-829. Date of Electronic Publication: 2020 Jul 16.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
Neisseria meningitidis, Serogroup B*
Disease Outbreaks/prevention & control ; Humans ; Self Report ; Students ; Universities ; Vaccination
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A re-assessment of 4CMenB vaccine effectiveness against serogroup B invasive meningococcal disease in England based on an incidence model.
Autorzy:
Argante L; GSK, Siena, Italy. .
Abbing-Karahagopian V; GSK, Amsterdam, The Netherlands.
Vadivelu K; GSK, Siena, Italy.
Rappuoli R; GSK, Siena, Italy.
Medini D; GSK, Siena, Italy.
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2021 Dec 11; Vol. 21 (1), pp. 1244. Date of Electronic Publication: 2021 Dec 11.
Typ publikacji:
Journal Article
MeSH Terms:
Meningococcal Infections*/epidemiology
Meningococcal Infections*/prevention & control
Meningococcal Vaccines*
Neisseria meningitidis, Serogroup B*
Bayes Theorem ; England/epidemiology ; Humans ; Incidence ; Infant ; Serogroup ; Vaccine Efficacy
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
An open-label randomised controlled trial evaluating the efficacy of a meningococcal serogroup B (4CMenB) vaccine on Neisseria gonorrhoeae infection in gay and bisexual men: the MenGO study protocol.
Autorzy:
Thng C; Gold Coast Sexual Health, Southport Community Health Precinct, Southport, Qld, 4215, Australia. .; Institute for Glycomics, Griffith University, Southport, Qld, 4215, Australia. .
Semchenko EA; Institute for Glycomics, Griffith University, Southport, Qld, 4215, Australia.
Hughes I; Gold Coast University Hospital, Southport, Qld, 4215, Australia.
O'Sullivan M; Gold Coast Sexual Health, Southport Community Health Precinct, Southport, Qld, 4215, Australia.
Seib KL; Institute for Glycomics, Griffith University, Southport, Qld, 4215, Australia.
Pokaż więcej
Źródło:
BMC public health [BMC Public Health] 2023 Mar 30; Vol. 23 (1), pp. 607. Date of Electronic Publication: 2023 Mar 30.
Typ publikacji:
Clinical Trial Protocol; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Gonorrhea*/prevention & control
Meningococcal Infections*/prevention & control
Meningococcal Vaccines*/therapeutic use
Sexual and Gender Minorities*
Humans ; Male ; Australia/epidemiology ; Clinical Trials, Phase III as Topic ; Neisseria gonorrhoeae ; Neisseria meningitidis, Serogroup B ; Randomized Controlled Trials as Topic ; Serogroup ; Sexual Behavior
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Genomic surveillance of Neisseria meningitidis serogroup B invasive strains: Diversity of vaccine antigen types, Brazil, 2016-2018.
Autorzy:
de Lemos APS; Centre of Bacteriology, Institute Adolfo Lutz (IAL), São Paulo, Brazil.
Sacchi CT; Strategic Laboratory, Institute Adolfo Lutz (IAL), São Paulo, Brazil.
Gonçalves CR; Strategic Laboratory, Institute Adolfo Lutz (IAL), São Paulo, Brazil.
Camargo CH; Centre of Bacteriology, Institute Adolfo Lutz (IAL), São Paulo, Brazil.
Andrade AL; Institute of Tropical Pathology and Public Health, Federal University of Goiás, Goiânia, Brazil.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2020 Dec 21; Vol. 15 (12), pp. e0243375. Date of Electronic Publication: 2020 Dec 21 (Print Publication: 2020).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Genetic Variation/*genetics
Meningococcal Infections/*genetics
Meningococcal Vaccines/*genetics
Neisseria meningitidis, Serogroup B/*genetics
Adolescent ; Adult ; Aged ; Brazil/epidemiology ; Child ; Child, Preschool ; Female ; Genome, Bacterial/genetics ; Genomics ; Humans ; Immunogenicity, Vaccine/genetics ; Immunogenicity, Vaccine/immunology ; Infant ; Male ; Meningococcal Infections/epidemiology ; Meningococcal Infections/immunology ; Meningococcal Vaccines/immunology ; Meningococcal Vaccines/therapeutic use ; Middle Aged ; Multilocus Sequence Typing/methods ; Neisseria meningitidis, Serogroup B/pathogenicity ; Serogroup ; Whole Genome Sequencing ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Genomic analysis of the meningococcal ST-4821 complex-Western clade, potential sexual transmission and predicted antibiotic susceptibility and vaccine coverage.
Autorzy:
Lucidarme J; Meningococcal Reference Unit, Public Health England, Manchester Royal Infirmary, Manchester, United Kingdom.
Zhu B; National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, PR China.
Xu L; National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, PR China.
Bai X; Meningococcal Reference Unit, Public Health England, Manchester Royal Infirmary, Manchester, United Kingdom.
Gao Y; National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, PR China.
González-López JJ; Department of Clinical Microbiology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Mulhall R; Irish Meningitis and Sepsis Reference Laboratory, Children's Health Ireland at Temple Street, Dublin, Ireland.
Scott KJ; Bacterial Respiratory Infection Service, Scottish Microbiology Reference Laboratory, Glasgow Royal Infirmary, Glasgow, United Kingdom.
Smith A; Bacterial Respiratory Infection Service, Scottish Microbiology Reference Laboratory, Glasgow Royal Infirmary, Glasgow, United Kingdom.; College of Medical, Veterinary & Life Sciences, Glasgow Dental Hospital & School, University of Glasgow, Glasgow, United Kingdom.
Stefanelli P; Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
Stenmark B; Department of Laboratory Medicine, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
Torpiano P; Department of Child and Adolescent Health, Mater Dei Hospital, Msida, Malta.
Tzanakaki G; National Meningitis Reference Laboratory, Dept. of Public Health Policy, School of Public Health, University of West Attica, Athens, Greece.
Borrow R; Meningococcal Reference Unit, Public Health England, Manchester Royal Infirmary, Manchester, United Kingdom.
Shao Z; National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, PR China.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2020 Dec 10; Vol. 15 (12), pp. e0243426. Date of Electronic Publication: 2020 Dec 10 (Print Publication: 2020).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Meningitis, Meningococcal/*genetics
Meningococcal Infections/*genetics
Neisseria meningitidis/*genetics
Neisseria meningitidis, Serogroup B/*genetics
Adult ; Antigens, Bacterial/genetics ; Europe ; Female ; Genetic Variation ; Genomics/methods ; Genotype ; Homosexuality, Male/genetics ; Humans ; Male ; Meningitis, Meningococcal/complications ; Meningitis, Meningococcal/microbiology ; Meningitis, Meningococcal/pathology ; Meningococcal Infections/complications ; Meningococcal Infections/microbiology ; Meningococcal Infections/pathology ; Meningococcal Vaccines/genetics ; Meningococcal Vaccines/immunology ; Multilocus Sequence Typing ; Neisseria meningitidis/pathogenicity ; Neisseria meningitidis, Serogroup B/pathogenicity ; Serogroup ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Meningococcal B vaccine antigen FHbp variants among disease-causing Neisseria meningitidis B isolates, Italy, 2014-2017.
Autorzy:
Carannante A; Department Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
Fazio C; Department Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
Neri A; Department Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
Lista F; Scientific Department, Army Medical Center, Rome, Italy.
Fillo S; Scientific Department, Army Medical Center, Rome, Italy.
Ciammaruconi A; Scientific Department, Army Medical Center, Rome, Italy.
Vacca P; Department Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
Stefanelli P; Department Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2020 Nov 11; Vol. 15 (11), pp. e0241793. Date of Electronic Publication: 2020 Nov 11 (Print Publication: 2020).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Neisseria meningitidis, Serogroup B/*immunology
Antigens, Bacterial/immunology ; Antigens, Bacterial/metabolism ; Bacterial Outer Membrane Proteins/immunology ; Bacterial Outer Membrane Proteins/metabolism ; Bacterial Proteins/immunology ; Bacterial Proteins/metabolism ; Bacterial Vaccines/immunology ; Genetic Variation ; Meningococcal Vaccines/immunology ; Meningococcal Vaccines/metabolism ; Multilocus Sequence Typing ; Neisseria meningitidis, Serogroup B/metabolism ; Porins/immunology ; Porins/metabolism ; Software ; Whole Genome Sequencing
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Meningococcal Serogroup B Disease in Vaccinated Children.
Autorzy:
Soler-Garcia A; Malalties Infeccioses i Resposta Inflamatòria Sistèmica en Pediatria, Institut de Recerca Pediàtrica, Hospital Sant Joan de Déu, Barcelona, Spain.
Fernández de Sevilla M; Malalties Infeccioses i Resposta Inflamatòria Sistèmica en Pediatria, Institut de Recerca Pediàtrica, Hospital Sant Joan de Déu, Barcelona, Spain.; Departament de Pediatria, Universitat de Barcelona, Barcelona, Spain.; CIBER de Epidemiología y Salud Pública, CIBERESP, Madrid, Spain.; Red de Investigación Translacional en Infectología Pediátrica, RITIP, Madrid, Spain.
Abad R; Unidad de Neisseria, Listeria y Bordetella, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain.
Esteva C; Malalties Infeccioses i Resposta Inflamatòria Sistèmica en Pediatria, Institut de Recerca Pediàtrica, Hospital Sant Joan de Déu, Barcelona, Spain.; CIBER de Epidemiología y Salud Pública, CIBERESP, Madrid, Spain.
Alsina L; Malalties Infeccioses i Resposta Inflamatòria Sistèmica en Pediatria, Institut de Recerca Pediàtrica, Hospital Sant Joan de Déu, Barcelona, Spain.; Departament de Pediatria, Universitat de Barcelona, Barcelona, Spain.; Clinical Immunology and Primary Immunodeficiencies Unit, Pediatric Allergy and Clinical Immunology Department, Hospital Sant Joan de Déu, Barcelona, Spain.; Clinical Immunology Unit Hospital Sant Joan de Déu-Hospital Clínic Barcelona, Barcelona, Spain.
Vázquez J; Unidad de Neisseria, Listeria y Bordetella, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain.
Muñoz-Almagro C; Malalties Infeccioses i Resposta Inflamatòria Sistèmica en Pediatria, Institut de Recerca Pediàtrica, Hospital Sant Joan de Déu, Barcelona, Spain.; CIBER de Epidemiología y Salud Pública, CIBERESP, Madrid, Spain.; Red de Investigación Translacional en Infectología Pediátrica, RITIP, Madrid, Spain.; Departament de Medicina, Universitat Internacional de Catalunya, Barcelona, Spain.
Noguera-Julian A; Malalties Infeccioses i Resposta Inflamatòria Sistèmica en Pediatria, Institut de Recerca Pediàtrica, Hospital Sant Joan de Déu, Barcelona, Spain.; Departament de Pediatria, Universitat de Barcelona, Barcelona, Spain.; CIBER de Epidemiología y Salud Pública, CIBERESP, Madrid, Spain.; Red de Investigación Translacional en Infectología Pediátrica, RITIP, Madrid, Spain.
Pokaż więcej
Źródło:
Journal of the Pediatric Infectious Diseases Society [J Pediatric Infect Dis Soc] 2020 Sep 17; Vol. 9 (4), pp. 454-459.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Meningococcal Infections/*microbiology
Meningococcal Vaccines/*administration & dosage
Neisseria meningitidis, Serogroup B/*isolation & purification
Child ; Child, Preschool ; Female ; Humans ; Infant ; Male ; Meningococcal Infections/immunology ; Meningococcal Infections/prevention & control ; Meningococcal Vaccines/immunology ; Neisseria meningitidis, Serogroup B/immunology ; Risk Factors ; Spain
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Targeted vaccination campaigns of teenagers after two clusters of B invasive meningococcal disease in Brittany, France, 2017.
Autorzy:
Pivette M; Santé publique France, French national public health agency, Direction des régions, Cellule Bretagne, Rennes, France. .
Taha MK; Institut Pasteur, National Reference Center for Meningococci, Paris, France.
Barret AS; Santé publique France, French national public health agency, Direction des maladies infectieuses, Saint-Maurice, France.
Polard E; Pharmacovigilance, Pharmacoepidemiology and Drug Information Center, Rennes University Hospital, Rennes, France.
Hautier MB; Direction académique de l'Education Nationale, School Health services, Saint-Brieuc, France.
Dufour JB; Agence régionale de santé Bretagne, Regional health agency, Rennes, France.
Faisant M; Santé publique France, French national public health agency, Direction des régions, Cellule Bretagne, Rennes, France.
King LA; Santé publique France, French national public health agency, Direction des régions, Cellule Bretagne, Rennes, France.
Antona D; Santé publique France, French national public health agency, Direction des maladies infectieuses, Saint-Maurice, France.
Levy-Bruhl D; Santé publique France, French national public health agency, Direction des maladies infectieuses, Saint-Maurice, France.
Tillaut H; Santé publique France, French national public health agency, Direction des régions, Cellule Bretagne, Rennes, France.
Scanff A; Santé publique France, French national public health agency, Direction des régions, Cellule Bretagne, Rennes, France.
Morival C; Pharmacovigilance, Pharmacoepidemiology and Drug Information Center, Rennes University Hospital, Rennes, France.
Aranda Grau JH; Agence régionale de santé Bretagne, Regional health agency, Rennes, France.
Guillaumot P; Agence régionale de santé Bretagne, Regional health agency, Rennes, France.
Gagnière B; Santé publique France, French national public health agency, Direction des régions, Cellule Bretagne, Rennes, France.
Pokaż więcej
Źródło:
BMC public health [BMC Public Health] 2020 Sep 10; Vol. 20 (1), pp. 1382. Date of Electronic Publication: 2020 Sep 10.
Typ publikacji:
Journal Article
MeSH Terms:
Meningococcal Infections*/epidemiology
Meningococcal Infections*/prevention & control
Meningococcal Vaccines*
Neisseria meningitidis, Serogroup B*
Adolescent ; Adult ; Child ; France/epidemiology ; Humans ; Immunization Programs ; Infant ; Vaccination ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Outbreak strain characterisation and pharyngeal carriage detection following a protracted group B meningococcal outbreak in adolescents in South-West England.
Autorzy:
Clark SA; Meningococcal Reference Unit, Public Health England, Manchester, UK. .
Lucidarme J; Meningococcal Reference Unit, Public Health England, Manchester, UK.
Angel G; Public Health England South West, Bristol, UK.
Lekshmi A; Meningococcal Reference Unit, Public Health England, Manchester, UK.
Morales-Aza B; School of Cellular and Molecular Medicine, University of Bristol, Bristol, UK.
Willerton L; Meningococcal Reference Unit, Public Health England, Manchester, UK.
Campbell H; Immunisation and Countermeasures Division, Public Health England, London, UK.
Gray SJ; Meningococcal Reference Unit, Public Health England, Manchester, UK.
Ladhani SN; Immunisation and Countermeasures Division, Public Health England, London, UK.
Wade M; Public Health England South West, Bristol, UK.
Ramsay M; Immunisation and Countermeasures Division, Public Health England, London, UK.
Yates J; Public Health England South West, Bristol, UK.
Finn A; School of Cellular and Molecular Medicine, University of Bristol, Bristol, UK.
Borrow R; Meningococcal Reference Unit, Public Health England, Manchester, UK.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2019 Jul 10; Vol. 9 (1), pp. 9990. Date of Electronic Publication: 2019 Jul 10.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Carrier State/*epidemiology
Meningococcal Infections/*epidemiology
Meningococcal Vaccines/*administration & dosage
Neisseria meningitidis, Serogroup B/*classification
Pharynx/*microbiology
Adolescent ; Antigens, Bacterial/genetics ; Bacterial Proteins/genetics ; Bacteriological Techniques ; Disease Outbreaks ; England ; Humans ; Meningococcal Vaccines/immunology ; Neisseria meningitidis, Serogroup B/genetics ; Neisseria meningitidis, Serogroup B/isolation & purification ; Phylogeny ; Porins/genetics ; Whole Genome Sequencing/methods
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
US College Students Are at Increased Risk for Serogroup B Meningococcal Disease.
Autorzy:
Marshall GS; Department of Pediatrics, University of Louisville, Louisville, Kentucky.
Dempsey AF; Department of Pediatrics, University of Colorado, Aurora, Colorado.
Srivastava A; Pfizer Vaccines Medical Development, Scientific and Clinical Affairs, Collegeville, Pennsylvania.
Isturiz RE; Pfizer Vaccines Medical Development, Scientific and Clinical Affairs, Collegeville, Pennsylvania.
Pokaż więcej
Źródło:
Journal of the Pediatric Infectious Diseases Society [J Pediatric Infect Dis Soc] 2020 Apr 30; Vol. 9 (2), pp. 244-247.
Typ publikacji:
Journal Article
MeSH Terms:
Meningococcal Vaccines*
Neisseria meningitidis, Serogroup B*
Students*
Universities*
Meningococcal Infections/*epidemiology
Adolescent ; Carrier State ; Disease Outbreaks/prevention & control ; Disease Outbreaks/statistics & numerical data ; Female ; Humans ; Incidence ; Male ; Meningococcal Infections/prevention & control ; Risk ; United States/epidemiology ; Vaccination/statistics & numerical data ; Vaccines, Conjugate ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Multi-component meningococcal serogroup B (MenB)-4C vaccine induces effective opsonophagocytic killing in children with a complement deficiency.
Autorzy:
van den Broek B; Pediatric Infectious Diseases and Immunology, Amalia Children's Hospital, Nijmegen, the Netherlands.; Expertise Center for Immunodeficiency and Autoinflammation (REIA), Radboudumc, Nijmegen, the Netherlands.; Section Pediatric Infectious Diseases, Laboratory of Medical Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, the Netherlands.; Radboud Center for Infectious Diseases, Radboudumc, Nijmegen, the Netherlands.
van Els CACM; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
Kuipers B; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
van Aerde K; Pediatric Infectious Diseases and Immunology, Amalia Children's Hospital, Nijmegen, the Netherlands.; Expertise Center for Immunodeficiency and Autoinflammation (REIA), Radboudumc, Nijmegen, the Netherlands.; Section Pediatric Infectious Diseases, Laboratory of Medical Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, the Netherlands.; Radboud Center for Infectious Diseases, Radboudumc, Nijmegen, the Netherlands.
Henriet SS; Pediatric Infectious Diseases and Immunology, Amalia Children's Hospital, Nijmegen, the Netherlands.; Expertise Center for Immunodeficiency and Autoinflammation (REIA), Radboudumc, Nijmegen, the Netherlands.; Section Pediatric Infectious Diseases, Laboratory of Medical Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, the Netherlands.; Radboud Center for Infectious Diseases, Radboudumc, Nijmegen, the Netherlands.
de Groot R; Section Pediatric Infectious Diseases, Laboratory of Medical Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, the Netherlands.; Radboud Center for Infectious Diseases, Radboudumc, Nijmegen, the Netherlands.
de Jonge MI; Section Pediatric Infectious Diseases, Laboratory of Medical Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, the Netherlands.; Radboud Center for Infectious Diseases, Radboudumc, Nijmegen, the Netherlands.
Langereis JD; Section Pediatric Infectious Diseases, Laboratory of Medical Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, the Netherlands.; Radboud Center for Infectious Diseases, Radboudumc, Nijmegen, the Netherlands.
van der Flier M; Pediatric Infectious Diseases and Immunology, Amalia Children's Hospital, Nijmegen, the Netherlands.; Expertise Center for Immunodeficiency and Autoinflammation (REIA), Radboudumc, Nijmegen, the Netherlands.; Section Pediatric Infectious Diseases, Laboratory of Medical Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, the Netherlands.; Radboud Center for Infectious Diseases, Radboudumc, Nijmegen, the Netherlands.
Pokaż więcej
Źródło:
Clinical and experimental immunology [Clin Exp Immunol] 2019 Dec; Vol. 198 (3), pp. 381-389. Date of Electronic Publication: 2019 Oct 01.
Typ publikacji:
Journal Article
MeSH Terms:
Hereditary Complement Deficiency Diseases/*immunology
Meningitis, Meningococcal/*immunology
Meningococcal Vaccines/*immunology
Neisseria meningitidis, Serogroup B/*immunology
Opsonin Proteins/*immunology
Phagocytosis/*immunology
Adolescent ; Adult ; Antibodies, Bacterial/immunology ; Child ; Complement Factor H/immunology ; Complement Factor H/metabolism ; Female ; Hereditary Complement Deficiency Diseases/microbiology ; Hereditary Complement Deficiency Diseases/therapy ; Humans ; Male ; Meningitis, Meningococcal/microbiology ; Meningitis, Meningococcal/therapy ; Meningococcal Vaccines/administration & dosage ; Neisseria meningitidis, Serogroup B/physiology ; Opsonin Proteins/metabolism ; Vaccination
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Genomic surveillance of invasive meningococcal disease in the Czech Republic, 2015-2017.
Autorzy:
Krizova P; National Reference Laboratory for Meningococcal Infections, Centre for Epidemiology and Microbiology, National Institute of Public Health, Prague, Czech Republic.
Honskus M; National Reference Laboratory for Meningococcal Infections, Centre for Epidemiology and Microbiology, National Institute of Public Health, Prague, Czech Republic.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2019 Jul 11; Vol. 14 (7), pp. e0219477. Date of Electronic Publication: 2019 Jul 11 (Print Publication: 2019).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Meningococcal Infections/*genetics
Neisseria meningitidis/*genetics
Neisseria meningitidis, Serogroup B/*genetics
Antigens, Bacterial/genetics ; Czech Republic/epidemiology ; Genome, Bacterial/genetics ; Genomics ; Humans ; Meningococcal Infections/epidemiology ; Meningococcal Infections/microbiology ; Neisseria meningitidis/pathogenicity ; Neisseria meningitidis, Serogroup B/pathogenicity ; Vaccination ; Whole Genome Sequencing
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Characterization of meningococcal carriage isolates from Greece by whole genome sequencing: Implications for 4CMenB vaccine implementation.
Autorzy:
Kesanopoulos K; National Meningitis Reference Laboratory (NMRL), Dept of Public Health, National School of Public Health, Athens, Greece.
Bratcher HB; Department of Zoology, Peter Medawar Building, University of Oxford, Oxford, United Kingdom.
Hong E; Institute Pasteur, Invasive Bacterial Infections Unit, Paris, France.
Xirogianni A; National Meningitis Reference Laboratory (NMRL), Dept of Public Health, National School of Public Health, Athens, Greece.
Papandreou A; National Meningitis Reference Laboratory (NMRL), Dept of Public Health, National School of Public Health, Athens, Greece.
Taha MK; Institute Pasteur, Invasive Bacterial Infections Unit, Paris, France.
Maiden MCJ; Department of Zoology, Peter Medawar Building, University of Oxford, Oxford, United Kingdom.
Tzanakaki G; National Meningitis Reference Laboratory (NMRL), Dept of Public Health, National School of Public Health, Athens, Greece.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2018 Dec 28; Vol. 13 (12), pp. e0209919. Date of Electronic Publication: 2018 Dec 28 (Print Publication: 2018).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Genetic Variation*
Genome, Bacterial*
Genome-Wide Association Study*
High-Throughput Nucleotide Sequencing*
Neisseria meningitidis, Serogroup B*/genetics
Neisseria meningitidis, Serogroup B*/isolation & purification
Meningococcal Vaccines/*administration & dosage
Female ; Greece ; Humans ; Male ; Meningitis, Meningococcal/genetics ; Meningitis, Meningococcal/microbiology ; Meningitis, Meningococcal/prevention & control
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A homopolymeric adenosine tract in the promoter region of nspA influences factor H-mediated serum resistance in Neisseria meningitidis.
Autorzy:
Claus H; Institute for Hygiene and Microbiology, University of Würzburg, Würzburg, Germany.
Hubert K; Institute for Hygiene and Microbiology, University of Würzburg, Würzburg, Germany.
Becher D; Institute for Microbiology, University of Greifswald, Greifswald, Germany.
Otto A; Institute for Microbiology, University of Greifswald, Greifswald, Germany.
Pawlik MC; Institute for Hygiene and Microbiology, University of Würzburg, Würzburg, Germany.
Lappann I; Institute for Hygiene and Microbiology, University of Würzburg, Würzburg, Germany.
Strobel L; Institute for Hygiene and Microbiology, University of Würzburg, Würzburg, Germany.
Vogel U; Institute for Hygiene and Microbiology, University of Würzburg, Würzburg, Germany.
Johswich K; Institute for Hygiene and Microbiology, University of Würzburg, Würzburg, Germany. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2019 Feb 25; Vol. 9 (1), pp. 2736. Date of Electronic Publication: 2019 Feb 25.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Bacterial Outer Membrane Proteins/*metabolism
Meningitis, Meningococcal/*metabolism
Neisseria meningitidis, Serogroup B/*physiology
Bacterial Outer Membrane Proteins/genetics ; Complement Factor H/metabolism ; Gene Deletion ; Host-Pathogen Interactions ; Humans ; Neisseria meningitidis, Serogroup B/genetics ; Poly A/genetics ; Promoter Regions, Genetic ; Transcriptome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Clustered intergenic region sequences as predictors of factor H Binding Protein expression patterns and for assessing Neisseria meningitidis strain coverage by meningococcal vaccines.
Autorzy:
Cayrou C; Department of Genetics and Genome Biology, University of Leicester, Leicester, United Kingdom.
Akinduko AA; Department of Mathematics, University of Leicester, Leicester, United Kingdom.
Mirkes EM; Department of Mathematics, University of Leicester, Leicester, United Kingdom.
Lucidarme J; Meningococcal Reference Unit, Public Health England, Manchester Royal Infirmary, Manchester, United Kingdom.
Clark SA; Meningococcal Reference Unit, Public Health England, Manchester Royal Infirmary, Manchester, United Kingdom.
Green LR; Department of Genetics and Genome Biology, University of Leicester, Leicester, United Kingdom.
Cooper HJ; School of Biosciences, University of Birmingham, Birmingham, United Kingdom.
Morrissey J; Department of Genetics and Genome Biology, University of Leicester, Leicester, United Kingdom.
Borrow R; Meningococcal Reference Unit, Public Health England, Manchester Royal Infirmary, Manchester, United Kingdom.
Bayliss CD; Department of Genetics and Genome Biology, University of Leicester, Leicester, United Kingdom.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2018 May 30; Vol. 13 (5), pp. e0197186. Date of Electronic Publication: 2018 May 30 (Print Publication: 2018).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antigens, Bacterial/*immunology
Bacterial Proteins/*immunology
DNA, Bacterial/*immunology
DNA, Intergenic/*immunology
Meningitis, Meningococcal/*prevention & control
Meningococcal Vaccines/*immunology
Neisseria meningitidis, Serogroup B/*immunology
Alleles ; Antigens, Bacterial/genetics ; Bacterial Proteins/genetics ; Base Sequence ; Complement Factor H/genetics ; Complement Factor H/immunology ; DNA, Bacterial/genetics ; DNA, Intergenic/genetics ; Gene Expression ; Humans ; Immunogenicity, Vaccine ; Infant ; Meningitis, Meningococcal/genetics ; Meningitis, Meningococcal/immunology ; Meningococcal Vaccines/administration & dosage ; Meningococcal Vaccines/genetics ; Multigene Family ; Neisseria meningitidis, Serogroup B/genetics ; Promoter Regions, Genetic ; Protein Binding ; Sequence Alignment ; Vaccination
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The next chapter for group B meningococcal vaccines.
Autorzy:
Wang NY; a School of Medicine , Monash University , Melbourne , Australia.; b Department of Paediatrics , Oxford Vaccine Group , Oxford , UK.
Pollard AJ; b Department of Paediatrics , Oxford Vaccine Group , Oxford , UK.; c NIHR Oxford Biomedical Research Centre, University of Oxford , Oxford , UK.
Pokaż więcej
Źródło:
Critical reviews in microbiology [Crit Rev Microbiol] 2018 Feb; Vol. 44 (1), pp. 95-111. Date of Electronic Publication: 2017 May 30.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Meningitis, Meningococcal/*microbiology
Meningococcal Vaccines/*immunology
Neisseria meningitidis, Serogroup B/*immunology
Animals ; Humans ; Meningitis, Meningococcal/immunology ; Meningitis, Meningococcal/prevention & control ; Meningococcal Vaccines/administration & dosage ; Meningococcal Vaccines/genetics ; Neisseria meningitidis, Serogroup B/genetics ; Vaccination
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 171

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies